Hong Kong Licensed Treatment Centres: 18 Licences – Qualification & Selection Guide

Hong Kong has 18 licensed assisted reproduction treatment centres, regulated by the Human Reproductive Technology Authority. This article explains the meaning of the 18 licences, centre types, selection points, and treatment process, helping users understand the qualification requirements and evaluation methods of licensed centres.

Hong Kong Licensed Treatment Centres: 18 Licences – Qualification & Selection Guide

Opening: Check-up report scenario

 

An AMH test report shows a value of 0.8 ng/mL, and FSH has risen to 12 IU/L. Holding this report, 38-year-old Ms. L began to systematically learn about assisted reproductive treatment. Her first question was: which treatment centres are legal and qualified? The answer to this question points directly to Hong Kong's licensed assisted reproduction treatment centres – currently there are 18 licensed institutions (i.e., 18 treatment centres issued licences by the Hong Kong Human Reproductive Technology Authority).

From the perspective of a reproductive medicine knowledge base, this article compiles the qualification background, selection points, treatment process, and common questions regarding these 18 licensed treatment centres, for the reference of those who need to understand Hong Kong's assisted reproduction service system.

1. What do the 18 licensed treatment centres in Hong Kong refer to?

Hong Kong has a total of 18 licensed treatment centres, referring to the total number of medical institutions that have been issued a "Assisted Reproduction Treatment Centre Licence" by the Hong Kong Human Reproductive Technology Authority (HTRA) as of the present. These centres are permitted to perform assisted reproductive technologies such as in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), embryo freezing, and frozen embryo transfer.

Licences are issued under the Human Reproductive Technology Ordinance (Cap. 561). Licensed centres must meet the following core conditions:

  • Equipped with embryology laboratories and equipment meeting standards;
  • Have qualified reproductive doctors, embryologists, and nursing teams;
  • Establish an ethics committee to supervise embryo manipulation and research;
  • Regularly report treatment data and results to the HTRA;
  • Undergo on-site inspections and audits by the HTRA.

The 18 licences cover public hospital reproductive centres, private hospital reproductive centres, and specialist fertility clinics. Licences are not permanent and must be renewed periodically, with each renewal subject to HTRA review.

2. Why are there 18 licensed treatment centres in Hong Kong?

Assisted reproductive technology in Hong Kong began with the birth of the first test-tube baby in 1986. With technological development, Hong Kong established a strict statutory regulatory framework. The number of licences is not set arbitrarily but is determined by the following factors:

  • Strict regulatory standards: The HTRA has clear requirements for laboratory standards, personnel qualifications, and operational procedures. Some applicant institutions did not obtain licences because they failed to meet these standards;
  • Limited professional talent: Reproductive medicine requires a team of senior reproductive doctors, embryologists, genetic counsellors, etc. The talent pool directly affects licence approval;
  • Market demand and balance: The distribution of the 18 centres covers the main medical areas of Hong Kong Island, Kowloon, and the New Territories, basically meeting the needs of local and some overseas patients;
  • Licence classification management: Some institutions hold limited licences (e.g., only for sperm processing or embryo freezing) rather than full IVF licences, and are therefore not counted among the 18 treatment centres.

Of these 18 centres, about one-third are reproductive centres affiliated with public hospitals, while the rest are private hospitals or specialist clinics. There are differences in service scope, technical focus, and fee structures among different centres.

3. Key differences between licensed centres

Although all are licensed treatment centres, the 18 institutions differ significantly in the following dimensions, which directly affect treatment choices:

Comparison Dimension Public Hospital Reproductive Centre Private Hospital Reproductive Centre Specialist Fertility Clinic
Waiting Time Longer (3-12 months, depending on case) Shorter (initial appointment within 1-4 weeks) Short (1-2 weeks)
Cost Level Lower (charged according to public hospital rates) Moderate to higher Higher (personalised service)
PGT Technology Offered by some centres, requires assessment Offered by most centres Offered by some centres or sent out
Embryo Freezing Offered, relatively uniform policy Offered, flexible storage period Offered, personalised plans
Donor Eggs/Sperm Long waiting time, limited sources Relatively flexible, but must comply with regulations Depends on centre policy
Language Services Mainly Cantonese, some English Cantonese, English, Mandarin Multilingual services more common

When choosing, you need to consider your own situation: age, ovarian reserve, previous treatment history, time schedule, budget, and language preference. Different centres also have their own experiential tendencies in ovulation induction protocols, embryo culture strategies, and transfer policies (e.g., single embryo transfer vs. multiple embryo transfer).

4. Details easily overlooked when choosing a licensed centre

When confirming whether a centre is licensed, the following details are often overlooked:

  • Licence type and scope: Some institutions hold a "Sperm Processing Licence" or "Embryo Freezing Licence" rather than a full "Assisted Reproduction Treatment Centre Licence". The former cannot perform IVF or ICSI procedures. When checking the licence, verify the specific scope of permission.
  • Licence validity period: Licences have renewal cycles. You can check the latest status on the HTRA official website. A centre being licensed in the past does not mean it is still currently valid.
  • Whether the laboratory is on-site: A few centres collaborate with external laboratories, and embryos may be sent to other institutions for culture or testing. Confirm the laboratory location and whether it is within HTRA supervision.
  • Ethics committee registration: Licensed centres must establish an independent ethics committee to oversee embryo manipulation, genetic testing, and research projects. You can ask about the composition and review process of the centre's ethics committee.
  • Data reporting transparency: Licensed centres must submit annual treatment data to the HTRA, including cycle numbers, clinical pregnancy rates, live birth rates, etc. Some centres make this data public; you can request to see it.

5. Common misconceptions and pitfalls

Based on practitioner observations, the following misconceptions frequently arise during consultations:

  • Misconception 1: All reproductive centres are licensed. Some institutions in Hong Kong offer "fertility counselling," "pregnancy preparation guidance," or "Chinese medicine调理," but have not obtained an HTRA licence and cannot perform any assisted reproductive technology procedures. Distinguish between "medical counselling institutions" and "licensed treatment centres."
  • Misconception 2: All 18 centres can perform all procedures. Some centres do not offer PGT, some have strict restrictions on donor gametes, and others do not accept older or complex cases. Confirm the centre's service scope before choosing.
  • Misconception 3: Being licensed guarantees success rates. A licence is a basic condition for legal operation, not a bonus point. Success rates are influenced by multiple factors such as age, cause of infertility, and centre experience. Do not use the number of licences as a basis for judging success rates.
  • Misconception 4: The process is the same for overseas and local patients. Non-Hong Kong residents may face longer waiting times or higher fees at some public centres. Private centres are relatively flexible, but visa and document requirements should be confirmed in advance.

6. Basic process of IVF at a licensed centre in Hong Kong

The specific procedures vary slightly between centres, but the overall framework is consistent:

  1. Initial consultation and assessment: Bring previous test reports (AMH, FSH, semen analysis, chromosome reports, etc.). The doctor assesses fertility status and formulates an initial plan.
  2. Registration and tests: Complete infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis, etc.), uterine cavity assessment (e.g., hysteroscopy or ultrasound), semen analysis (male partner), etc. Some centres require marriage certificate and identification documents.
  3. Ovarian stimulation: Choose an ovulation induction protocol (long protocol, short protocol, antagonist protocol, etc.) based on ovarian reserve. The cycle lasts about 10-14 days, during which follicle development is monitored.
  4. Egg retrieval: Transvaginal egg retrieval under ultrasound guidance, usually with intravenous anaesthesia. The number of eggs retrieved depends on the number of follicles.
  5. Embryo culture and testing: After egg retrieval, IVF or ICSI fertilisation is performed. Embryos are cultured to day 3 or day 5-6 (blastocyst). If needed, PGT genetic testing is performed (results take about 4-6 weeks).
  6. Embryo transfer: Select 1-2 embryos for transfer. The procedure requires no anaesthesia. Remaining embryos can be frozen for storage.
  7. Luteal support and pregnancy test: Progesterone medication is used for support after transfer. A blood test for HCG is performed approximately 12-14 days later to confirm pregnancy.

The entire cycle (from ovarian stimulation to pregnancy test) usually takes 4-6 weeks. If PGT testing is involved, the cycle extends to 8-10 weeks.

7. Compilation of frequently asked questions

The following questions are frequently raised during patient education and counselling. They are answered here collectively:

7.1 How to check the latest list of licensed centres in Hong Kong?

The Hong Kong Human Reproductive Technology Authority website (www.htra.gov.hk) publishes the list of all licensed institutions and their licence status. It is recommended to check directly to ensure the information is up-to-date. Lists provided by some agencies or websites may be outdated or incomplete.

7.2 Do licensed centres in Hong Kong accept patients from Mainland China?

Most private licensed centres accept Mainland patients, but they require valid identification documents (Hong Kong/Macau Entry Permit or passport), notarised and translated marriage certificates. Public centres have quotas for non-local residents. It is advisable to plan 3-6 months in advance.

7.3 How to interpret the clinical pregnancy rates of licensed centres?

The HTRA requires centres to report pregnancy rates and live birth rates by age group (<35 years, 35-39 years, 40-42 years, >42 years). When reviewing data, note: ① whether it is stratified by age; ② whether frozen embryo cycles are included; ③ the sample size (data from very few cycles has limited reference value).

7.4 What is the difference between licensed centres in Hong Kong and reproductive centres in top-tier hospitals in Mainland China?

Licensed centres in Hong Kong are under the single regulatory authority of the HTRA, with uniform requirements for laboratory standards, ethical review, and data transparency. Reproductive centres in Mainland China are regulated by the National Health Commission, with variations in implementation details across different provinces and cities. There is no fundamental technical difference between the two, but they differ in service models, process efficiency, and language environment.

7.5 Can I still do IVF at a licensed centre in Hong Kong with low AMH?

Yes. Low AMH does not mean no eggs at all, but the number of eggs retrieved may be lower. Licensed centres will conduct a comprehensive assessment based on AMH, FSH, and antral follicle count (AFC) to develop an individualised ovulation induction protocol. For those of advanced age or with low ovarian reserve, it is recommended to complete chromosome testing, uterine cavity assessment, and genetic counselling in advance.

8. Practitioner observation: How to rationally view the 18 licensed centres

As a reproductive doctor, I have observed some phenomena worth sharing in daily work:

First, a licence is a baseline, not an advantage. Being licensed is a necessary condition for legal operation, not a bonus point. When choosing a centre, pay more attention to its clinical pregnancy rate (stratified by age), embryologist experience, laboratory quality control system, and multidisciplinary collaboration capability (e.g., whether it has genetic counsellors and psychological counsellors).

Second, do not judge technical level by the number of licences. Among the 18 centres, there are significant differences in technical reserves, laboratory standards, and team stability. Some centres have advanced time-lapse imaging incubators and AI-assisted embryo scoring systems, while others focus more on personalised services. Choose according to your own situation.

Third, overseas patients need to pay more attention to communication efficiency. The treatment cycle involves a large amount of information transfer: adjustments to ovulation induction protocols, embryo status updates, and interpretation of test results. When selecting a centre, confirm whether it has a smooth multilingual communication mechanism to avoid decision-making affected by information gaps.

Fourth, the degree of data disclosure varies among licensed centres. The HTRA requires centres to submit data, but the method of disclosure differs. You can proactively request treatment data from the centre for the past 1-2 years, focusing on the clinical pregnancy rates and live birth rates for the three age groups: under 35, 35-39, and over 40. The smaller the number of cycles in the data, the greater the statistical fluctuation, so view it rationally.

AMH FSH Antral Follicle Count Semen Analysis Chromosome Testing Hysteroscopy Genetic Counselling Ovarian Stimulation Egg Retrieval Embryo Culture PGT Frozen Embryo Transfer Luteal Support Reproductive Doctor Embryologist Ethics Committee Human Reproductive Technology Authority
Risk Reminder: Assisted reproductive treatment involves medical risks, including but not limited to Ovarian Hyperstimulation Syndrome (OHSS), multiple pregnancy, and embryo transfer failure. As legally operating institutions, licensed centres will provide necessary risk disclosure and informed consent procedures. Before deciding on treatment, it is recommended to complete a comprehensive fertility assessment and physical examination, and fully communicate your personal medical history, family genetic history, and medication use with the reproductive doctor.

When choosing a licensed centre, verify the licence status through the official channels of the Hong Kong Human Reproductive Technology Authority and avoid obtaining information through informal intermediaries. If you experience severe discomfort during treatment (such as bloating, difficulty breathing, bleeding, etc.), seek medical attention immediately.
Check-up Reminder: Before planning assisted reproductive treatment at a licensed centre in Hong Kong, it is recommended to complete the following tests in advance: AMH, FSH, LH, Estradiol, Thyroid Function, Infectious Disease Screening (Hepatitis B, Hepatitis C, HIV, Syphilis), Semen Analysis (male partner), Chromosome Karyotype Analysis (both partners). Some test results are valid for 3-6 months, so schedule rechecks according to the treatment timeline.

—— Reproductive Medicine Knowledge Base · Licensed Centre Special Topic

0 comments
Leave a Reply